Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.95 | -18.70 |
| PEG Ratio (TTM) | -2.28 | -2.66 |
| P/S Ratio (TTM) | 0.93 | 3.42 |
| P/B Ratio (TTM) | 2.11 | 3.72 |
| P/FCF Ratio (TTM) | 7.08 | 24.10 |
| Price to 5YR AVG Earnings Ratio | 25.89 | 11.00 |
| Price to 5YR AVG FCF Ratio | 12.19 | 8.27 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.10% | 3.84% |
| ROE (TTM) | 14.84% | 10.19% |
| Net Profit Margin (TTM) | 6.31% | 27.16% |
| ROIC 5YR AVG | 13.44% | 15.74% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.30% | 35.66% | 38.44% |
| Revenue | 1.78% | 9.11% | 7.32% |
| Net Income | -5.93% | 35.61% | 36.84% |
| Cash Flow | 163.89% | 22.81% | 27.09% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.74 | 8.53 |
| Quick Ratio (TTM) | 2.74 | 8.53 |
| D/E Ratio (TTM) | 0.40 | 1.12 |
| Interest Coverage (TTM) | 7.28 | 13.33 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.06 | 2.16 |
| LTL to 5YR AVG FCF | 2.33 | -2.82 |
| Shares Outstanding Growth 5YR AVG | -1.95% | -1.74% |